GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Tecon Biology Co Ltd (SZSE:002100) » Definitions » Debt-to-EBITDA

Tecon Biology Co (SZSE:002100) Debt-to-EBITDA : 4.55 (As of Sep. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Tecon Biology Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Tecon Biology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥3,627 Mil. Tecon Biology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥2,120 Mil. Tecon Biology Co's annualized EBITDA for the quarter that ended in Sep. 2024 was ¥1,263 Mil. Tecon Biology Co's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 was 4.55.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Tecon Biology Co's Debt-to-EBITDA or its related term are showing as below:

SZSE:002100' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -33.8   Med: 2.73   Max: 28.69
Current: -33.8

During the past 13 years, the highest Debt-to-EBITDA Ratio of Tecon Biology Co was 28.69. The lowest was -33.80. And the median was 2.73.

SZSE:002100's Debt-to-EBITDA is ranked worse than
100% of 1497 companies
in the Consumer Packaged Goods industry
Industry Median: 2.05 vs SZSE:002100: -33.80

Tecon Biology Co Debt-to-EBITDA Historical Data

The historical data trend for Tecon Biology Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tecon Biology Co Debt-to-EBITDA Chart

Tecon Biology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.27 2.71 28.69 6.29 -14.39

Tecon Biology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -171.45 -1.82 13.78 5.82 4.55

Competitive Comparison of Tecon Biology Co's Debt-to-EBITDA

For the Packaged Foods subindustry, Tecon Biology Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tecon Biology Co's Debt-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Tecon Biology Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Tecon Biology Co's Debt-to-EBITDA falls into.



Tecon Biology Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Tecon Biology Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4807.791 + 1588.288) / -444.511
=-14.39

Tecon Biology Co's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3627.053 + 2119.602) / 1263.148
=4.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2024) EBITDA data.


Tecon Biology Co  (SZSE:002100) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Tecon Biology Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Tecon Biology Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Tecon Biology Co Business Description

Traded in Other Exchanges
N/A
Address
High-tech Zone in Changchun Road, 528 Tiankang Business Building, Xinjiang, Urumqi, CHN, 830011
Tecon Biology Co Ltd is engaged in the production and sales of veterinary biological products and animal disease prevention, modern pig science breeding and breeding, feed research and development and production, and pig slaughtering and processing. The company mainly operates its businesses within domestic markets, with Xinjiang Province as its main market.
Executives
Wang Xiao Supervisors
Pan Yi Ping Executives
Xu Heng Executives
Wu Xiang Yong Director
Sun Wei Hong Independent director
Wu Ming Qi Executives
Wang Xin An Director
Geng Li Xin Directors, executives
Che Xin Hui Supervisors

Tecon Biology Co Headlines

No Headlines